Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
The SNP rs2248359-C, neighboring the CYP24A1 gene encoding a protein involved in vitamin D3 degradation, has been suggested to link MS risk and vitamin D metabolism in the brain (Ramasamy et al., 2014).
Source: Genes associated with MS susceptibility SNPs can be modulated in OPCs by IFN-γ. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Mixed research settings
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Mice were kept with the following light/dark cycle: dawn 6:00 to 7:00, daylight 7:00 to 18:00, dusk 18:00 to 19:00, and night 19:00 to 6:00; they were housed to a maximum number of five per cage in individually ventilated cages (IVC Sealsafe GM500, Tecniplast).
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Epigenomic priming of immune genes implicates oligodendroglia in multiple sclerosis susceptibility
Study design awaiting verification · Neuron · 2022
Original publication title
Epigenomic priming of immune genes implicates oligodendroglia in multiple sclerosis susceptibility
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
SUMMARY
Multiple sclerosis (MS) is characterized by a targeted attack on oligodendroglia (OLG) and myelin by immune cells, which are thought to be the main drivers of MS susceptibility. We found that immune genes exhibit a primed chromatin state in single mouse and human OLG in a non-disease context, compatible with transitions to immune-competent states in MS. We identified BACH1 and STAT1 as transcription factors involved in immune gene regulation in oligodendrocyte precursor cells (OPCs). A subset of immune genes presents bivalency of H3K4me3/H3K27me3 in OPCs, with Polycomb inhibition leading to their increased activation upon interferon gamma (IFN-γ) treatment.
Some MS susceptibility single-nucleotide polymorphisms (SNPs) overlap with these regulatory regions in mouse and human OLG. Treatment of mouse OPCs with IFN-γ leads to chromatin architecture remodeling at these loci and altered expression of interacting genes. Thus, the susceptibility for MS may involve OLG, which therefore constitutes novel targets for immunological-based therapies for MS.
In brief
Meijer, Agirre, et al. show that mouse and human oligodendroglia present open chromatin at immune genes and MS susceptibility single-nucleotide polymorphisms in homeostasis and disease. Transcriptional activation of these open chromatin regions involves transcription factors such as BACH1 and STAT1 and changes in histone modification deposition and chromatin architecture.
Authors’ abstract
SUMMARY
Multiple sclerosis (MS) is characterized by a targeted attack on oligodendroglia (OLG) and myelin by immune cells, which are thought to be the main drivers of MS susceptibility. We found that immune genes exhibit a primed chromatin state in single mouse and human OLG in a non-disease context, compatible with transitions to immune-competent states in MS. We identified BACH1 and STAT1 as transcription factors involved in immune gene regulation in oligodendrocyte precursor cells (OPCs). A subset of immune genes presents bivalency of H3K4me3/H3K27me3 in OPCs, with Polycomb inhibition leading to their increased activation upon interferon gamma (IFN-γ) treatment.
Some MS susceptibility single-nucleotide polymorphisms (SNPs) overlap with these regulatory regions in mouse and human OLG. Treatment of mouse OPCs with IFN-γ leads to chromatin architecture remodeling at these loci and altered expression of interacting genes. Thus, the susceptibility for MS may involve OLG, which therefore constitutes novel targets for immunological-based therapies for MS.
In brief
Meijer, Agirre, et al. show that mouse and human oligodendroglia present open chromatin at immune genes and MS susceptibility single-nucleotide polymorphisms in homeostasis and disease. Transcriptional activation of these open chromatin regions involves transcription factors such as BACH1 and STAT1 and changes in histone modification deposition and chromatin architecture.
Publication and source details
Original title: Epigenomic priming of immune genes implicates oligodendroglia in multiple sclerosis susceptibility
Mandy Meijer; Eneritz Agirre; Mukund Kabbe; Cassandra A. van Tuijn; Abeer Heskol; Chao Zheng; Ana Mendanha Falcão; Marek Bartosovic; Leslie Kirby; Daniela Calini; Michael R. Johnson; M. Ryan Corces; Thomas J. Montine; Xingqi Chen; Howard Y. Chang; Dheeraj Malhotra; Gonçalo Castelo-Branco
Neuron · 2022
AUTHOR CONTRIBUTIONS
M.M., E.A., and G.C.-B. conceived and designed the project, interpreted data, and wrote the manuscript. M.M., M.K., C.A.v.T., A.H., C.Z., L.K., D.C., M.B., and A.M.F. performed experiments. E.A. performed computational analyses, M.K. performed ABC analysis. M.R.J. and D.M. provided human tissues for the multi-ome experiments. M.R.C., T.J.M., and H.Y.C. performed and provided human scATAC-seq data. X.C. and H.Y.C. provided valuable advice and input for Pi-ATAC experiments. G.C.-B. supervised the project. All the authors critically reviewed the manuscript and approved the final version.
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T10:17:57.704498+00:00
DOI: 10.1016/j.neuron.2021.12.034 · PMC9810341